347
Views
6
CrossRef citations to date
0
Altmetric
Original Research

The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran

, , , &
Pages 1349-1354 | Published online: 07 Aug 2019

References

  • Wiener C , Fauci AS , Braunwald E , et al. Harrison‘S Principles of Internal Medicine, Self-Assessment and Board Review . McGraw Hill Professional; 2008.
  • Weiss M , Steiner DF , Philipson LH . Insulin Biosynthesis, Secretion, Structure, and Structure-Activity Relationships. 2014 Available from: https://www.ncbi.nlm.nih.gov/pubmed/25905258.
  • Keenan DB , Mastrototaro JJ , Voskanyan G , Steil GM . Delays in minimally invasive continuous glucose monitoring devices: a review of current technology. J Diabetes Sci Technol . 2009;3(5):1207–1214. doi:10.1177/193229680900300528 20144438
  • Esteghamati A , Larijani B , Aghajani MH , et al. Diabetes in Iran: prospective analysis from first nationwide diabetes report of National program for prevention and control of diabetes (NPPCD-2016). Sci Rep . 2017;7(1):13461. doi:10.1038/s41598-017-13379-z 29044139
  • Azizi F, Gouya M, Vazirian P, Dolatshahi P, Habibian S. The diabetes prevention and control programme of the Islamic Republic of Iran.  East Mediterr Health J 2003;9(5–6):1114–21
  • Azizi F, Guoya M, Vazirian P, Dolatshati P, Habbibian S. Screening for type 2 diabetes in the Iranian national programme: a preliminary report. East Mediterr Health J 2003;9(5–6):1122–7.
  • Hoseini SM , Kalantari A , Afarideh M , et al. Evaluation of plasma MMP-8, MMP-9 and TIMP-1 identifies candidate cardiometabolic risk marker in metabolic syndrome: results from double-blinded nested case–control study. Metabolism . 2015;64(4):527–538. doi:10.1016/j.metabol.2014.12.009 25633268
  • Booya F , Bandarian F , Larijani B , Pajouhi M , Nooraei M , Lotfi J . Potential risk factors for diabetic neuropathy: a case control study. BMC Neurol . 2005;5(1):24. doi:10.1186/1471-2377-5-24 16336693
  • Ghanbari A , Yekta ZP , Roushan ZA , Lakeh NM . Assessment of factors affecting quality of life in diabetic patients in Iran. Public Health Nurs . 2005;22(4):311–322. doi:10.1111/j.0737-1209.2005.220406.x 16150012
  • Rossetti P , Porcellati F , Bolli GB , Fanelli CG . Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs. Diabetes Care . 2008;31(Supplement 2):S113–S20. doi:10.2337/dc08-s227 18227470
  • Mostafavian Z , Ghareh S , Torabian F , Yazdi MS , Khazaei MR . Data on insulin therapy refusal among type II diabetes mellitus patients in Mashhad, Iran. Data Brief . 2018;18:2047–2050. doi:10.1016/j.dib.2018.04.136 29904712
  • Mirahmadizadeh A, Delam H, Seif M, Banihashemi SA, Tabatabaee H. Factors Affecting Insulin Compliance in Patients with Type 2 Diabetes in South Iran, 2017: We Are Faced with Insulin Phobia. Iran J Med Sci 2019;44 (312):1–10.
  • Habibi R , Soltani M , Habibi G . Factors affecting rejection by diabetics for insulin therapy. Iran J Diabetes and Lipid Disorders . 2012;11(4):366–376.
  • Goyal A , Kumar A . Effect of a diabetes education camp on perception of insulin therapy in patients of type-2 diabetes mellitus. Med J DY Patil Vidyapeeth . 2018;11(2):137.
  • Farsaei S , Radfar M , Heydari Z , Abbasi F , Qorbani M . Insulin adherence in patients with diabetes: risk factors for injection omission. Prim Care Diabetes . 2014;8(4):338–345. doi:10.1016/j.pcd.2014.03.001 24721139
  • Almaghaslah D, Abdelrhman AK, AL-Masdaf SK, Mohammed L, Majrashi BMM, Asiri WM, et al. Factors contributing to non-adherence to insulin therapy among type 1 and type2 diabetes mellitus patients in Asser region, Saudi Arabia. Biomedical Research 2018;29(10): 2090–95.
  • Chen -C-C , Chang M-P , Hsieh M-H , Huang C-Y , Liao L-N , Li T-C . Evaluation of perception of insulin therapy among Chinese patients with type 2 diabetes mellitus. Diabetes Metab . 2011;37(5):389–394. doi:10.1016/j.diabet.2010.12.008 21458350
  • Jha S , Panda M , Kumar S , et al. Psychological insulin resistance in patients with type 2 diabetes. J Assoc Physicians India . 2015;63(7):33–39.
  • Ghadiri-Anari A , Fazaelipoor Z , Mohammadi SM . Insulin refusal in Iranian patients with poorly controlled type 2 diabetes mellitus. Acta Med Iran . 2013;51(8):567–571.24026995
  • Peyrot M , Rubin RR , Kruger DF , Travis LB . Correlates of insulin injection omission. Diabetes Care . 2010;33(2):240–245. doi:10.2337/dc09-1348 20103556
  • Brod M , Pohlman B , Kongsø JH . Insulin administration and the impacts of forgetting a dose. Patient-Patient-Centered Outcomes Res . 2014;7(1):63–71. doi:10.1007/s40271-013-0029-9
  • Nam S , Chesla C , Stotts NA , Kroon L , Janson SL . Factors associated with psychological insulin resistance in individuals with type 2 diabetes. Diabetes Care . 2010;33:1747–1749. doi:10.2337/dc10-0099 20435797
  • Simmons JH , McFann KK , Brown AC , et al. Reliability of the diabetes fear of injecting and self-testing questionnaire in pediatric patients with type 1 diabetes. Diabetes Care . 2007;30(4):987–988. doi:10.2337/dc06-1553 17392558
  • Polinski JM , Smith BF , Curtis BH , et al. Barriers to insulin progression among patients with type 2 diabetes: a systematic review. Diabetes Educ . 2013;39(1):53–65. doi:10.1177/0145721712467696 23192599
  • Aikens JE , Piette JD . Diabetic patients’ medication underuse, illness outcomes, and beliefs about antihyperglycemic and antihypertensive treatments. Diabetes Care . 2009;32(1):19–24. doi:10.2337/dc08-1533 18852334
  • Piette JD , Heisler M , Wagner TH . Cost-related medication underuse among chronically III adults: the treatments people forgo, how often, and who is at risk. Am J Public Health . 2004;94(10):1782–1787.15451750
  • Nam S , Chesla C , Stotts NA , Kroon L , Janson SL . Barriers to diabetes management: patient and provider factors. Diabetes Res Clin Pract . 2011;93(1):1–9. doi:10.1016/j.diabres.2011.02.002 21382643
  • Hunt J , Rozenfeld Y , Shenolikar R . Effect of patient medication cost share on adherence and glycemic control. Manag Care . 2009;18(7):47–53.
  • Davies M , Gagliardino JJ , Gray L , Khunti K , Mohan V , Hughes R . Real‐world factors affecting adherence to insulin therapy in patients with type 1 or type 2 diabetes mellitus: a systematic review. Diabetes Res . 2013;30(5):512–524. doi:10.1111/dme.12128
  • Polonsky WH , Fisher L , Guzman S , Villa-Caballero L , Edelman SV . Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care . 2005;28(10):2543–2545.16186296
  • Karter AJ , Subramanian U , Saha C , et al. Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care . 2010;33(4):733–735. doi:10.2337/dc09-1184 20086256
  • Wong S , Lee J , Ko Y , Chong M , Lam C , Tang W . Perceptions of insulin therapy amongst Asian patients with diabetes in Singapore. Diabetes Res . 2011;28(2):206–211. doi:10.1111/j.1464-5491.2010.03195.x
  • Brod M , Kongsø JH , Lessard S , Christensen TL . Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res . 2009;18(1):23. doi:10.1007/s11136-009-9478-y 19039679
  • Shah SMA , Butt Z , Hussain K . Factors leading to psychological insulin resistance among patients with type 2 diabetes mellitus. Ann Pak Inst Med Sci . 2017; 13(3):226–30.
  • Guimarães C , Marra CA , Gill S , Meneilly G , Simpson S , Godoy AL . Exploring patients’ perceptions for insulin therapy in type 2 diabetes: a Brazilian and Canadian qualitative study. Patient Prefer Adherence . 2010;4:171. doi:10.2147/PPA.S10178 20694179